FDA-Inspected Site

Namsa

2 FDA inspections are on record for Namsa in Minneapolis, United States.

483· Form 483 issued

Minneapolis, United States · Last updated July 9, 2026

Overview

  • 2 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2021-09-21.

At a glance

Inspections

2

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
30 Aug 2021 – 21 Sep 2021Medical Devices & Rad Health483View 483 →
1 Nov 2017 – 17 Nov 2017Medical Devices & Rad Health483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

21 Sep 2021
21 CFR 58.195(b)

Archives: retention for appropriate time

Cited by Nicole C Victoria

17 Nov 2017
21 CFR 58.31(f)

Management: personnel understand their functions

Cited by Nicole C Victoria

17 Nov 2017
21 CFR 58.33(e)

Study director: follow GLP regulations

Cited by Nicole C Victoria

17 Nov 2017
21 CFR 58.35(a)

QAU: monitor facilities, etc.

Cited by Nicole C Victoria

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 58.195(b)Cited across public-safe Form 483 observations1x
21 CFR 58.31(f)Cited across public-safe Form 483 observations1x
21 CFR 58.33(e)Cited across public-safe Form 483 observations1x
21 CFR 58.35(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Namsa's 2 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat